Skip to main content

Published locations for Trial immunosuppressive therapy benefits outweigh long-term lymphoma risks in IBD

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Trial immunosuppressive therapy benefits outweigh long-term lymphoma risks in IBD

User login

  • Reset your password
  • /content/trial-immunosuppressive-therapy-benefits-outweigh-long-term-lymphoma-risks-ibd
  • /familypracticenews/article/79987/pulmonology/trial-immunosuppressive-therapy-benefits-outweigh-long
  • /gihepnews/article/79987/pulmonology/trial-immunosuppressive-therapy-benefits-outweigh-long-term
  • /internalmedicinenews/article/79987/pulmonology/trial-immunosuppressive-therapy-benefits-outweigh
  • /rheumatologynews/article/79987/pulmonology/trial-immunosuppressive-therapy-benefits-outweigh-long
  • /pulmonary-health-hub/article/79987/pulmonology/trial-immunosuppressive-therapy-benefits-outweigh
  • /rheumatology/article/79987/pulmonology/trial-immunosuppressive-therapy-benefits-outweigh-long-term
  • /internalmedicine/article/79987/pulmonology/trial-immunosuppressive-therapy-benefits-outweigh-long
  • /familymedicine/article/79987/pulmonology/trial-immunosuppressive-therapy-benefits-outweigh-long-term
  • /chestphysician/article/79987/pulmonology/trial-immunosuppressive-therapy-benefits-outweigh-long-term